[go: up one dir, main page]

Robinson, 1961 - Google Patents

Preparation of Lysolecithin

Robinson, 1961

View PDF
Document ID
15261199139241198335
Author
Robinson N
Publication year
Publication venue
Journal of Pharmacy and Pharmacology

External Links

Snippet

The first extensive investigation of the preparation, physical and chemical properties of lysolecithin was made by Levene and his colleagues. In 1923, Levene and Rolf prepared lysolecithin by the digestion of egg yolk in m/15 phosphate buffer with cobra venom as a …
Continue reading at lib3.dss.go.th (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Robinson Preparation of Lysolecithin
US4710490A (en) Compositions containing ganglioside molecules with enhanced angiogenic activity
Ambache Further studies on the preparation, purification and nature of irin
Smith et al. The lethal effect of endotoxins on the chick embryo
Mackenna et al. The composition of the surface skin fat (‘sebum’) from the human forearm
Saqib et al. Rationalizing ethnopharmacological uses of Alternanthera sessilis: A folk medicinal plant of Pakistan to manage diarrhea, asthma and hypertension
EP0253022A1 (en) Method for treatment of angina and myocardial infarctions with omental lipids
Anderson et al. The chemistry of the lipoids of tubercle bacilli
Wrissenberg Calcinogenic glycosides
JPS63501718A (en) How to enhance the healing of mammalian epithelial wounds
US4888324A (en) Method for enhancing angiogenesis with lipid containing molecules
Brooks et al. Tumour-promoting and hyperplastic effects of phorbol and daphnane esters in CD-1 mouse skin and a synergistic effect of calcium ionophore with the non-promoting activator of protein kinase C, sapintoxin A
Best The Croonian Lecture The lipotropic agents in the protection of the liver, kidney, heart and other organs of experimental animals
Lundholm et al. Influence of nicotinic acid, niceritrol and β-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs
Peter et al. Experimental myotonia and hypocholesterolemic agents
Gaffield The Veratrum alkaloids: natural tools for studying embryonic development
Larson et al. Some effects of nicotine and smoking on metabolic functions
Crompton et al. Production of ethanol and succinate by Moniliformis dubius (Acanthocephala)
Klein et al. Defective lipemia clearing response to heparin in idiopathic hyperlipemia
Savitsky Control of radiation hemorrhage with splenic extracts
Subbiah et al. Regression of naturally occurring atherosclerotic lesions in pigeon aorta by intestinal bypass surgery: Early changes in arterial cholesteryl ester metabolim
Eiber et al. Quantitative studies on the clearing effect of heparin
Klibansky et al. Chemical and biochemical studies in human fetuses affected with Niemann-Pick disease type A
Sherman Diet, Hormones, and Atherosclerosis: A Review of Research Grants Supported by the National Heart Institute, Fiscal Years 1949-1958
NZ217905A (en) Angiogenic composition containing angiogenic lipids